GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fuji Pharma Co Ltd (TSE:4554) » Definitions » Long-Term Capital Lease Obligation

Fuji Pharma Co (TSE:4554) Long-Term Capital Lease Obligation : 円4,311 Mil (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Fuji Pharma Co Long-Term Capital Lease Obligation?

Fuji Pharma Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was 円4,311 Mil.

Fuji Pharma Co's quarterly Long-Term Capital Lease Obligation increased from Sep. 2023 (円3,241 Mil) to Dec. 2023 (円4,440 Mil) but then declined from Dec. 2023 (円4,440 Mil) to Mar. 2024 (円4,311 Mil).

Fuji Pharma Co's annual Long-Term Capital Lease Obligation declined from Sep. 2021 (円2,508 Mil) to Sep. 2022 (円2,259 Mil) but then increased from Sep. 2022 (円2,259 Mil) to Sep. 2023 (円3,241 Mil).


Fuji Pharma Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Fuji Pharma Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fuji Pharma Co Long-Term Capital Lease Obligation Chart

Fuji Pharma Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,014.00 1,444.00 2,508.00 2,259.00 3,241.00

Fuji Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,454.00 3,356.00 3,241.00 4,440.00 4,311.00

Fuji Pharma Co  (TSE:4554) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Fuji Pharma Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Fuji Pharma Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Fuji Pharma Co (TSE:4554) Business Description

Industry
Traded in Other Exchanges
Address
5-7 Sanban-cho, Chiyoda-ku, Tokyo, JPN, 102-0075
Fuji Pharma Co.,Ltd. is the development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products.

Fuji Pharma Co (TSE:4554) Headlines

No Headlines